Symptomatic Venous Thromboembolism (VTE)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Symptomatic Venous Thromboembolism (VTE) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07213778

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip…

This study is researching an experimental drug called REGN7508 versus Acetylsalicylic Acid (ASA) (each called "study drug"). The study is focused on adults unde…

United States2,000 participantsStarted 2025-11-24

Treatment: REGN7508, Acetylsalicylic Acid (ASA)

All recent trials (10 shown)

WithdrawnNot Applicable

NCT03804125

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and S…

To characterize and analyze the number, type and incidence of adverse events/suspected adverse drug reactions in patients treated with Apixaban, according to th…

Location not specified0Started 2021-09-01

UnknownPhase 2

NCT02679664

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

The SAVER pilot is a randomized, open-label pilot study to determine the feasibility of recruitment. In addition to feasibility data, the investigators will car…

Canada312 participantsStarted 2016-11

Treatment: Rosuvastatin

Completed

Symptomatic Venous Thromboembolism (VTE)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip…

All recent trials (10 shown)

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and S…

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip…

All recent trials (10 shown)

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and S…

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin…

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Veno…